0

Votre panier



TOTAL HT
TOTAL TTC
fr en

Colin MCGUCKIN

CTIBIOTECH

Colin MCGUCKIN

Informations

Biography
After early research on leukaemia, chronic anaemia’s & Stem Cell disorders he developed a programme using human tissues for research and therapeutics, which also involved biobanking. His group were first in the world to characterise and produce embryonic-like stem cells from a non-embryonic source - Umbilical Cord Blood. (McGuckin et al, Cell Proliferation, 38, 245-255, 2005) and first to make an artificial liver, nervous, pancreatic and a range of other tissues from Umbilical Cord, Cord Blood, and Adipose related stem cells. He became the UK’s first Full Professor of Regenerative Medicine (Newcastle University, 2005), leading clinical research in adult stem cells through to patients. He strongly believes in international industry-academic cooperation. In 2009 he became President and CSO of CTIBIOTECH creating “close-to-patient” human tissue models with advanced technologies like 3DBioprinting allowing for the next generation of personalised medicine.

Speaker at

OPENING SPEECH & TOPIC 1 // FROM RAW MATERIALS TO FINISHED PRODUCTS (PART ONE)

Conférence FROM RAW MATERIALS TO FINISHED PRODUCTS
05/07/2022 | 08:55 - 11:25

Ce site utilise des cookies pour optimiser le fonctionnement de la plateforme et, mesurer et cibler nos campagnes publicitaires.